Search
for
Sort by
Research 181–210 of 1000+
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5‐alpha reductase type 1
- Assessing finasteride-associated sexual dysfunction using the FAERS database
- Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men
- Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review
- Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia?
- Sexual dysfunction in men taking systemic dermatologic medication: A systematic review
- The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies
- Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia
- Body image and sexual interests in adolescents and young adults with Prader–Willi syndrome
- Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function
- Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors
- Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- Effects of testosterone replacement therapy on sexual interest, function, and behavior in HIV+ men
- Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System
- Sexual health in rheumatology
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
- Psychosocial Impairment as a Possible Cause of Sexual Dysfunction among Young Men with Mild Androgenetic Alopecia: A Cross-sectional Crowdsourcing Web-based Study.
- Polycystic ovarian syndrome elevates the distress of sexual pain in Iranian women with infertility
- Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- The effects of total laser pubic hair removal on sexual functions, body perception and self-esteem in women
- The Conception and Evaluation of Sexual Health Literature